New Zealand markets close in 5 hours 8 minutes

Twist Bioscience Corporation (TWST)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
56.05-2.83 (-4.81%)
At close: 04:00PM EDT
55.50 -0.55 (-0.98%)
After hours: 06:56PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.43B
Enterprise value 3.22B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)12.18
Price/book (mrq)6.12
Enterprise value/revenue 11.62
Enterprise value/EBITDA -35.26

Trading information

Stock price history

Beta (5Y monthly) 1.80
52-week change 3121.60%
S&P500 52-week change 321.66%
52-week high 359.60
52-week low 314.42
50-day moving average 348.93
200-day moving average 335.07

Share statistics

Avg vol (3-month) 31.16M
Avg vol (10-day) 3991.99k
Shares outstanding 558.23M
Implied shares outstanding 658.23M
Float 857.33M
% held by insiders 11.74%
% held by institutions 1113.93%
Shares short (28 Jun 2024) 49.57M
Short ratio (28 Jun 2024) 47.35
Short % of float (28 Jun 2024) 421.51%
Short % of shares outstanding (28 Jun 2024) 416.44%
Shares short (prior month 31 May 2024) 411.09M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -69.24%
Operating margin (ttm)-64.92%

Management effectiveness

Return on assets (ttm)-15.63%
Return on equity (ttm)-30.40%

Income statement

Revenue (ttm)277.49M
Revenue per share (ttm)4.83
Quarterly revenue growth (yoy)25.10%
Gross profit (ttm)N/A
EBITDA -161.18M
Net income avi to common (ttm)-192.14M
Diluted EPS (ttm)-3.36
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)293.34M
Total cash per share (mrq)5.04
Total debt (mrq)89.42M
Total debt/equity (mrq)15.96%
Current ratio (mrq)5.51
Book value per share (mrq)9.63

Cash flow statement

Operating cash flow (ttm)-86.51M
Levered free cash flow (ttm)-32.77M